Comparing frailty screening tools in breast cancer patients
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
This study is testing different ways to check for frailty in breast cancer patients over 50 to see which method best predicts their health outcomes during surgery and chemotherapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Chongqing Medical University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Chongqing) |
| Trial ID | NCT06467149 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of various frailty screening tools, including the FRAIL Scale, Tilburg Frailty Index, and Geriatric-8, in predicting adverse health outcomes for breast cancer patients. It focuses on patients aged 50 and older who are undergoing surgery and chemotherapy. The study aims to identify the most suitable frailty screening methods for this population, enhancing the understanding of frailty's impact on health outcomes in breast cancer care.
Who should consider this trial
Good fit: Ideal candidates for this study are breast cancer patients aged 50 and older who can walk independently or with assistance and are scheduled for surgery and chemotherapy.
Not a fit: Patients with communication disorders, severe mental disorders, other malignant tumors, or those in the terminal stage of breast cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the identification of frail breast cancer patients, leading to better tailored treatment plans and improved health outcomes.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown promise in using frailty screening tools to predict health outcomes in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of breast cancer * Age ≥50 years old * the treatment plan discussed by MDT includes surgery and chemotherapy * can walk on their own (with the assistance of walking aids) Exclusion Criteria: * Communication disorders * Mental disorders that can't cooperate normally * Combined with other malignant tumours * Terminal stage of the disease
Where this trial is running
Chongqing
- Ju Qiu — Chongqing, China (Recruiting)
Study contacts
- Principal investigator: Ling-Na kong — Tutor
- Study coordinator: ju qiu, Bachelor.
- Email: qiujuchongyi@163.com
- Phone: 18523569369
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.